Here’s what you should know:
1. Penn Medicine, New York City-based Columbia University and Rochester, Minn.-based Mayo Clinic partnered in 2011 to study the origins and pathogenesis of Barrett’s esophagus. NCI awarded the group $8 million initially.
2. The researchers are currently studying the microbiome and how it helps Barrett’s esophagus and esophageal adenocarcinoma develop.
3. Associate gastroenterology professor John Lynch, MD, PhD, said in a release, “We are grateful to the National Cancer Institute for this important continuation of funding. It will enable us to carry on our work with our partners, with the aim of converting our research findings into potential diagnosis, prevention, and treatment applications against this important disease.”
More articles on gastroenterology:
FDA accepts application for Salix Pharmaceuticals’ new bowel cleansing preparation — 4 key notes
Potentially infected scope at Kaiser Permanente facility puts 23 at risk & more: 4 GI practices in the news
GI center to know: The Digestive Health Institute of Montana
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
